Differences about effectiveness of CGM and treatment satisfaction between dulaglutide and omarigliptin.

Trial Profile

Differences about effectiveness of CGM and treatment satisfaction between dulaglutide and omarigliptin.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Oct 2017

At a glance

  • Drugs Dulaglutide (Primary) ; Omarigliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Oct 2017 Planned End Date changed from 31 May 2017 to 31 May 2018.
    • 20 Jul 2017 New trial record
    • 13 Jun 2017 Interim results (n=7) comparing glucose lowering effects of Dulaglutide and Omarigliptin, presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top